Drug Target Review2025-10-17T09:00:00
Scientists have linked rare mutations in SPNS1 to a previously unknown lipid recycling pathway in lysosomes, revealing how faulty fat processing can trigger muscle and liver disease.
Already a member? Sign in
By highlighting cutting-edge research and its practical applications, Drug Target Review enables readers to make decisions that accelerate innovation, translate discoveries into therapies, and create tangible benefits for patients worldwide.
By becoming a member you join a connected and collaborative community driving the industry forward. Member benefits include:
2026-09-22T07:00:00Z
Contributor Luca Lotta, Drug Target Review
2026-06-15T07:00:00
Contributor Professor Dipak Ramji, Drug Target Review
2026-08-06T06:08:00
Author Dr Jonathan Cohen-Gold
2026-07-01T06:30:00
Sponsored by BPS Bioscience, Dr Veronique Baron
2026-05-25T07:00:00
Contributor Professor Neville Sanjana
2025-04-02T14:00:00
Sponsored by Eurofins Discovery
2025-05-28T14:00:00
Sponsored by Eurofins DiscoverX
Site powered by Webvision Cloud